These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 31185650)

  • 1. MOB (Mps one Binder) Proteins in the Hippo Pathway and Cancer.
    Gundogdu R; Hergovich A
    Cells; 2019 Jun; 8(6):. PubMed ID: 31185650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mob Family Proteins: Regulatory Partners in Hippo and Hippo-Like Intracellular Signaling Pathways.
    Duhart JC; Raftery LA
    Front Cell Dev Biol; 2020; 8():161. PubMed ID: 32266255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NDR/LATS protein kinases in immunology and cancer biology.
    Sharif AAD; Hergovich A
    Semin Cancer Biol; 2018 Feb; 48():104-114. PubMed ID: 28579171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling.
    Hergovich A; Hemmings BA
    Biofactors; 2009; 35(4):338-45. PubMed ID: 19484742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ndr/Lats Kinases Bind Specific Mob-Family Coactivators through a Conserved and Modular Interface.
    Parker BW; Gogl G; Bálint M; Hetényi C; Reményi A; Weiss EL
    Biochemistry; 2020 May; 59(17):1688-1700. PubMed ID: 32250593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Structure of an NDR/LATS Kinase-Mob Complex Reveals a Novel Kinase-Coactivator System and Substrate Docking Mechanism.
    Gógl G; Schneider KD; Yeh BJ; Alam N; Nguyen Ba AN; Moses AM; Hetényi C; Reményi A; Weiss EL
    PLoS Biol; 2015 May; 13(5):e1002146. PubMed ID: 25966461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.
    Couzens AL; Knight JD; Kean MJ; Teo G; Weiss A; Dunham WH; Lin ZY; Bagshaw RD; Sicheri F; Pawson T; Wrana JL; Choi H; Gingras AC
    Sci Signal; 2013 Nov; 6(302):rs15. PubMed ID: 24255178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Roles of NDR Protein Kinases in Hippo Signalling.
    Hergovich A
    Genes (Basel); 2016 May; 7(5):. PubMed ID: 27213455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring the Kinase Activities of the LATS/NDR Protein Kinases.
    Hergovich A
    Methods Mol Biol; 2019; 1893():305-317. PubMed ID: 30565143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MOB control: reviewing a conserved family of kinase regulators.
    Hergovich A
    Cell Signal; 2011 Sep; 23(9):1433-40. PubMed ID: 21539912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential NDR/LATS interactions with the human MOB family reveal a negative role for human MOB2 in the regulation of human NDR kinases.
    Kohler RS; Schmitz D; Cornils H; Hemmings BA; Hergovich A
    Mol Cell Biol; 2010 Sep; 30(18):4507-20. PubMed ID: 20624913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian NDR protein kinases: from regulation to a role in centrosome duplication.
    Hergovich A; Cornils H; Hemmings BA
    Biochim Biophys Acta; 2008 Jan; 1784(1):3-15. PubMed ID: 17881309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippo pathway - brief overview of its relevance in cancer.
    Zygulska AL; Krzemieniecki K; Pierzchalski P
    J Physiol Pharmacol; 2017 Jun; 68(3):311-335. PubMed ID: 28820389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SAV1 promotes Hippo kinase activation through antagonizing the PP2A phosphatase STRIPAK.
    Bae SJ; Ni L; Osinski A; Tomchick DR; Brautigam CA; Luo X
    Elife; 2017 Oct; 6():. PubMed ID: 29063833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Hippo Pathway: Biology and Pathophysiology.
    Ma S; Meng Z; Chen R; Guan KL
    Annu Rev Biochem; 2019 Jun; 88():577-604. PubMed ID: 30566373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.
    Elkholi IE; Boulais J; Thibault MP; Phan HD; Robert A; Lai LB; Faubert D; Smith MJ; Gopalan V; Côté JF
    J Biol Chem; 2023 Sep; 299(9):105123. PubMed ID: 37536630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling.
    Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A
    Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and Biochemical Analyses of the Core Components of the Hippo Pathway.
    Ni L; Luo X
    Methods Mol Biol; 2019; 1893():239-256. PubMed ID: 30565138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Protein Interactions by
    Xiong S; Couzens AL; Kean MJ; Mao DY; Guettler S; Kurinov I; Gingras AC; Sicheri F
    Mol Cell Proteomics; 2017 Jun; 16(6):1111-1125. PubMed ID: 28373297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downstream of human NDR kinases: impacting on c-myc and p21 protein stability to control cell cycle progression.
    Cornils H; Kohler RS; Hergovich A; Hemmings BA
    Cell Cycle; 2011 Jun; 10(12):1897-904. PubMed ID: 21593588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.